(TBPH) Theravance Biopharma - Performance 29.5% in 12m
TBPH performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-31.17%
#85 in Peer-Group
Rel. Strength
74.93%
#1860 in Stock-Universe
Total Return 12m
29.46%
#34 in Peer-Group
Total Return 5y
-46.25%
#100 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 526 |
| High / Low | USD |
|---|---|
| 52 Week High | 11.25 USD |
| 52 Week Low | 7.66 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 88.69 |
| Buy/Sell Signal +-5 | -1.24 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TBPH (29.5%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.4% | 125% | 327% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.69% | 17.7% | 78.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
4.34% | -14.2% | 404% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.15% | 2.99% | 49.2% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-7.83% | 4.46% | 46.4% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.85% | -8.53% | 45.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: TBPH vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TBPH
| Total Return (including Dividends) | TBPH | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.08% | 2.04% | 4.55% |
| 3 Months | 23.52% | -7.24% | 10.78% |
| 12 Months | 29.46% | -5.41% | 14.71% |
| 5 Years | -46.25% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | TBPH | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -17.7% | 34.5% | 79.2% |
| 3 Months | 78.1% | -46.5% | 92.9% |
| 12 Months | 46% | -71.8% | 44.2% |
| 5 Years | -55% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th45.36 | -3.06% | -5.38% |
| 3 Month | %th77.84 | 33.16% | 11.50% |
| 12 Month | %th83.51 | 36.87% | 12.86% |
| 5 Years | %th48.97 | -62.56% | -74.71% |
FAQs
Does Theravance Biopharma (TBPH) outperform the market?
Yes,
over the last 12 months TBPH made 29.46%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months TBPH made 23.52%, while XLV made -7.24%.
Performance Comparison TBPH vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TBPH vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.4% | -5.6% | 11.2% | 15% |
| US NASDAQ 100 | QQQ | 0.6% | -6.6% | 9% | 14% |
| German DAX 40 | DAX | 1.6% | -1.1% | -1.8% | -1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.7% | -5.2% | 13.2% | 12% |
| Hongkong Hang Seng | HSI | 1.8% | -6.9% | -4.6% | -6% |
| India NIFTY 50 | INDA | 1.8% | -3.2% | 11.4% | 30% |
| Brasil Bovespa | EWZ | 0% | -8.9% | -13.3% | 16% |
TBPH vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.1% | -7.8% | 4.5% | 1% |
| Consumer Discretionary | XLY | 3% | -2.7% | 19.9% | 10% |
| Consumer Staples | XLP | 4.9% | 0.6% | 13% | 20% |
| Energy | XLE | 5.8% | -4.6% | 16.6% | 33% |
| Financial | XLF | 1.3% | -4.2% | 8.1% | 0% |
| Health Care | XLV | 2.4% | -3.1% | 18.4% | 35% |
| Industrial | XLI | 1.8% | -4.8% | 4.6% | 5% |
| Materials | XLB | 3.4% | -2.7% | 11.8% | 26% |
| Real Estate | XLRE | 5.9% | -1.1% | 13.8% | 17% |
| Technology | XLK | 0.1% | -10% | 7.9% | 18% |
| Utilities | XLU | 3.8% | -1.1% | 7.8% | 5% |
| Aerospace & Defense | XAR | -0.5% | -11% | -10.2% | -23% |
| Biotech | XBI | 3.6% | -3.2% | 25.1% | 40% |
| Homebuilder | XHB | 3.2% | -7.2% | 22.4% | 29% |
| Retail | XRT | 4.5% | -2.5% | 19.9% | 23% |
TBPH vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.7% | -6.20% | 20.5% | 40% |
| Natural Gas | UNG | 13.6% | 8.4% | 26.3% | 37% |
| Gold | GLD | 6.4% | 1.1% | -8.7% | -12% |
| Silver | SLV | 4.8% | -4.9% | -7.4% | 7% |
| Copper | CPER | 1.1% | -5.3% | -8.5% | 14% |
TBPH vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.6% | -4.7% | 14.4% | 27% |
| iShares High Yield Corp. Bond | HYG | 3.5% | -2.9% | 12.2% | 19% |